Canadian stroke best practice recommendations: Secondary prevention of stroke, sixth edition practice guidelines, update 2017

Holter-electrocardiogram-monitoring in patients with acute ischaemic stroke (Find-AF RANDOMISED ): an open-label randomised controlled trial

(2017) Rolf Wachter et al.   LANCET NEUROLOGY

Evolocumab and Clinical Outcomes in Patients with Cardiovascular Disease

(2017) Marc S. Sabatine et al.   NEW ENGLAND JOURNAL OF MEDICINE

Patent Foramen Ovale Closure or Antiplatelet Therapy for Cryptogenic Stroke

(2017) Lars Søndergaard et al.   NEW ENGLAND JOURNAL OF MEDICINE

Long-Term Outcomes of Patent Foramen Ovale Closure or Medical Therapy after Stroke

(2017) Jeffrey L. Saver et al.   NEW ENGLAND JOURNAL OF MEDICINE

Patent Foramen Ovale Closure or Anticoagulation vs. Antiplatelets after Stroke

(2017) Jean-Louis Mas et al.   NEW ENGLAND JOURNAL OF MEDICINE

Reporting Items for Updated Clinical Guidelines: Checklist for the Reporting of Updated Guidelines (CheckUp)

(2017) Robin W. M. Vernooij et al.   PLOS MEDICINE

2016 Canadian Cardiovascular Society Guidelines for the Management of Dyslipidemia for the Prevention of Cardiovascular Disease in the Adult

(2016) Todd J. Anderson et al.   CANADIAN JOURNAL OF CARDIOLOGY

Dual antiplatelet therapy after stroke or transient ischaemic attack - how long to treat? The duration of aspirin plus clopidogrel in stroke or transient ischaemic attack: a systematic review and meta-analysis

(2016) F. Ge et al.   EUROPEAN JOURNAL OF NEUROLOGY

Canadian Stroke Best Practice Recommendations: Acute Inpatient Stroke Care Guidelines, Update 2015

(2016) Leanne K Casaubon et al.   International Journal of Stroke

Canadian stroke best practice recommendations: Stroke rehabilitation practice guidelines, update 2015

(2016) Debbie Hebert et al.   International Journal of Stroke

Device Closure of Patent Foramen Ovale After Stroke

(2016) David M. Kent et al.   JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY

Global and regional effects of potentially modifiable risk factors associated with acute stroke in 32 countries (INTERSTROKE): a case-control study

(2016) Martin J O'Donnell et al.   LANCET

Global burden of stroke and risk factors in 188 countries, during 1990–2013: a systematic analysis for the Global Burden of Disease Study 2013

(2016) Valery L Feigin et al.   LANCET NEUROLOGY

One-Year Risk of Stroke after Transient Ischemic Attack or Minor Stroke

(2016) Pierre Amarenco et al.   NEW ENGLAND JOURNAL OF MEDICINE

Pioglitazone after Ischemic Stroke or Transient Ischemic Attack

(2016) Walter N. Kernan et al.   NEW ENGLAND JOURNAL OF MEDICINE

CPAP for Prevention of Cardiovascular Events in Obstructive Sleep Apnea

(2016) R. Doug McEvoy et al.   NEW ENGLAND JOURNAL OF MEDICINE

How to Monitor Patients Receiving Direct Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Practice Tool Endorsed by Thrombosis Canada, the Canadian Stroke Consortium, the Canadian Cardiovascular Pharmacists Network, and the Canadian Cardiovascular Society

(2015) David J. Gladstone et al.   ANNALS OF INTERNAL MEDICINE

Canadian Stroke Best Practice Recommendations: Hyperacute Stroke Care Guidelines, Update 2015

(2015) Leanne K. Casaubon et al.   International Journal of Stroke

Monogenic causes of stroke: now and the future

(2015) Rhea Y. Y. Tan et al.   JOURNAL OF NEUROLOGY

Antiplatelet treatment compared with anticoagulation treatment for cervical artery dissection (CADISS): a randomised trial

(2015)   LANCET NEUROLOGY

Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes

(2015) Bernard Zinman et al.   NEW ENGLAND JOURNAL OF MEDICINE

Percutaneous closure of patent foramen ovale in patients with cryptogenic embolism: a network meta-analysis

(2014) Stefan Stortecky et al.   EUROPEAN HEART JOURNAL

Canadian Stroke Best Practice Recommendations: Secondary Prevention of Stroke Guidelines, Update 2014

(2014) Shelagh B. Coutts et al.   International Journal of Stroke

Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1·25 million people

(2014) Eleni Rapsomaniki et al.   LANCET

Atrial Fibrillation in Patients with Cryptogenic Stroke

(2014) David J. Gladstone et al.   NEW ENGLAND JOURNAL OF MEDICINE

Cryptogenic Stroke and Underlying Atrial Fibrillation

(2014) Tommaso Sanna et al.   NEW ENGLAND JOURNAL OF MEDICINE

Clopidogrel Plus Aspirin Versus Warfarin in Patients With Stroke and Aortic Arch Plaques

(2014) Pierre Amarenco et al.   STROKE

Early Dual Versus Mono Antiplatelet Therapy for Acute Non-Cardioembolic Ischemic Stroke or Transient Ischemic Attack

(2013) Ka Sing Lawrence Wong et al.   CIRCULATION

Benefit of Warfarin Compared With Aspirin in Patients With Heart Failure in Sinus Rhythm

(2013) Shunichi Homma et al.   Circulation-Heart Failure

EHRA Practical Guide on the use of new oral anticoagulants in patients with non-valvular atrial fibrillation: executive summary†

(2013) Hein Heidbuchel et al.   EUROPEAN HEART JOURNAL

The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials

(2013)   LANCET

Aggressive medical treatment with or without stenting in high-risk patients with intracranial artery stenosis (SAMMPRIS): the final results of a randomised trial

(2013) Colin P Derdeyn et al.   LANCET

Secondary stroke prevention

(2013) Graeme J Hankey   LANCET NEUROLOGY

Closure of Patent Foramen Ovale versus Medical Therapy after Cryptogenic Stroke

(2013) John D. Carroll et al.   NEW ENGLAND JOURNAL OF MEDICINE

Percutaneous Closure of Patent Foramen Ovale in Cryptogenic Embolism

(2013) Bernhard Meier et al.   NEW ENGLAND JOURNAL OF MEDICINE

Bleeding of New Oral Anticoagulants for Stroke Prevention in Atrial Fibrillation: A Meta-Analysis of Randomized Controlled Trials

(2012) Joey S. W. Kwong et al.   CARDIOVASCULAR DRUGS AND THERAPY

Genetic risk factors for ischaemic stroke and its subtypes (the METASTROKE Collaboration): a meta-analysis of genome-wide association studies

(2012) Matthew Traylor et al.   LANCET NEUROLOGY

Warfarin and Aspirin in Patients with Heart Failure and Sinus Rhythm

(2012) Shunichi Homma et al.   NEW ENGLAND JOURNAL OF MEDICINE

Closure or Medical Therapy for Cryptogenic Stroke with Patent Foramen Ovale

(2012) Anthony J. Furlan et al.   NEW ENGLAND JOURNAL OF MEDICINE

Risk of recurrent stroke, myocardial infarction, or death in hospitalized stroke patients

(2010) W. Feng et al.   NEUROLOGY

Guidelines for the Primary Prevention of Stroke

(2010) Larry B. Goldstein et al.   STROKE

Randomized Trial of Warfarin, Aspirin, and Clopidogrel in Patients With Chronic Heart Failure

(2009) Barry M. Massie et al.   CIRCULATION

The effect of intensive glucose control on all-cause and cardiovascular mortality, myocardial infarction and stroke in persons with type 2 diabetes mellitus: a systematic review and meta-analysis

(2009) Steven P. Marso et al.   Diabetes & Vascular Disease Research

Aspirin in the primary and secondary prevention of vascular disease: collaborative meta-analysis of individual participant data from randomised trials

(2009)   LANCET

Short-Term and Long-Term Risk of Incident Ischemic Stroke After Transient Ischemic Attack

(2009) Evan L. Thacker et al.   STROKE

Grades of Recommendation for Antithrombotic Agents

(2008) Gordon H. Guyatt et al.   CHEST

Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes

(2008) William Duckworth et al.   NEW ENGLAND JOURNAL OF MEDICINE